Lumos Pharma Profit Margin

Lumos Pharma (LUMO) currently reports a profit margin of -1583.49% as of September 2024. That compares with -1816.93% in the prior-year period — up 12.8% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Lumos Pharma's profit margin history and peer comparisons.

Lumos Pharma's profit margin increased from -1816.93% to -1583.49% — a 12.8% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lumos Pharma's profit margin of -1583.49% is lower than the Healthcare sector average of 15.29%. That is roughly 10454.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Lumos Pharma's current -1583.49% should be judged against Healthcare norms (sector average: 15.29%) and against LUMO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1583.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Lumos Pharma, and consider following LUMO for alerts when major investors trade the stock.